질병 조기 발견용 바이오센서 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 구성요소, 용도, 재료 유형, 디바이스, 최종사용자, 기능, 솔루션

The global Biosensors for Early Disease Detection Market is projected to grow from $2.5 billion in 2025 to $9.0 billion by 2035, at a compound annual growth rate (CAGR) of 13.6%. The biosensors for early disease detection market is supported by expanding demand for rapid, minimally invasive, and decentralized diagnostic technologies. Adoption is being reinforced by the growing prevalence of chronic diseases, increasing emphasis on preventive healthcare, and broader use of point-of-care testing. Healthcare providers are increasingly evaluating biosensor platforms for continuous monitoring, biomarker detection, and earlier clinical intervention. Advances in nanomaterials, microfluidics, flexible electronics, wireless connectivity, and artificial intelligence are improving sensor sensitivity, portability, and functionality. Demand is also expanding across oncology, cardiovascular, metabolic, neurological, and infectious disease applications, while research collaborations and technology commercialization are strengthening the overall biosensor development ecosystem.

Type-based segmentation covers wearable, non-wearable, implantable, and ingestible biosensors, differentiated by sampling interface, biocompatibility, power architecture, connectivity, and monitoring duration. Wearables support continuous, non-invasive sensing from sweat, saliva, tears, or interstitial fluid; non-wearables serve laboratory and point-of-care workflows; implantables enable persistent internal measurements; ingestibles capture gastrointestinal and biochemical parameters. Their benefits include earlier biomarker identification, decentralized testing, longitudinal data, and reduced invasive procedures. Growth prospects remain strongest where miniaturization, flexible electronics, microfluidics, wireless communication, and artificial intelligence improve sensitivity, specificity, usability, and clinical interpretation. Increasing integration with remote monitoring platforms should broaden adoption beyond specialist settings into preventive and personalized healthcare.

Product-based segmentation includes electrochemical, optical, thermal, and piezoelectric biosensors, each pairing a biological recognition element with a transduction mechanism and signal-processing interface. Electrochemical platforms offer compact, low-power quantitative detection; optical systems provide high sensitivity and multiplexing; thermal devices measure reaction-associated heat changes; piezoelectric sensors detect mass or mechanical shifts. Applications span glucose, cardiac, infectious, cancer, neurological, and metabolic biomarker detection. Commercial momentum is supported by advances in nanomaterials, microfluidics, photonics, surface functionalization, and portable electronics, with optical and electrochemical architectures positioned for expanding multiplexed, rapid, and minimally invasive diagnostic applications across clinical and decentralized care.

Geographical Overview

North America maintains a strong position through advanced diagnostic infrastructure, extensive research capacity, established medtech manufacturing, and high utilization of point-of-care and connected health technologies. The region benefits from major academic medical centers, venture funding, clinical-trial networks, and regulatory pathways supporting novel biosensor development. Demand is anchored by chronic disease management, oncology screening, cardiovascular monitoring, and decentralized diagnostics. Partnerships among technology developers, hospitals, universities, and pharmaceutical companies accelerate translation from prototypes to commercial systems. U.S. regulatory activity around digital health and medical devices, together with public research funding, supports innovation, while reimbursement and evidence requirements continue shaping commercialization strategies across healthcare systems.

Asia-Pacific is expanding its biosensor ecosystem through healthcare digitization, medical-device manufacturing, biotechnology investment, and rising demand for accessible diagnostics. China, Japan, South Korea, India, Singapore, and Australia provide varied combinations of research expertise, electronics supply chains, hospital networks, and public health programs. Adoption is increasingly supported by wearable monitoring, portable testing, and locally developed sensor platforms aimed at chronic disease and infectious disease management. Investments in nanotechnology, flexible electronics, microfluidics, and artificial intelligence are strengthening domestic capabilities, while collaborations between universities, technology firms, and healthcare providers create pathways for scale. These conditions provide substantial room for future market expansion over the coming years.

Key Trends and Drivers

Smart Biosensing Enters the Era of Continuous Health Monitoring:

The market is shifting toward continuous, minimally invasive, and intelligent biosensing platforms that combine biomarker detection with wireless connectivity, artificial intelligence, microfluidics, and advanced materials. Wearable formats increasingly analyze accessible biofluids such as sweat, saliva, tears, and interstitial fluid, enabling longitudinal monitoring rather than episodic testing. Research is also advancing optical, electrochemical, and implantable architectures for neurological, cardiovascular, oncological, and metabolic applications, strengthening the transition toward predictive and personalized diagnostics.

The Push for Earlier Detection Fuels Next Generation Biosensor Adoption:

The rising need for earlier and more accessible disease detection is accelerating biosensor adoption across healthcare systems. Growing chronic disease burdens, demand for decentralized diagnostics, and limitations associated with invasive or infrequent conventional testing are encouraging development of rapid, sensitive, and portable sensing technologies. Biosensors can facilitate repeated biomarker measurements closer to patients, supporting earlier clinical decision-making, remote monitoring, and personalized intervention. WHO identifies screening and early diagnosis as important elements of noncommunicable-disease management, reinforcing the underlying healthcare demand for improved detection technologies.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Component
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Material Type
• 2.8 Key Market Highlights by Device
• 2.9 Key Market Highlights by Functionality
• 2.10 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Wearable Biosensors
  • 4.1.2 Non-Wearable Biosensors
  • 4.1.3 Implantable Biosensors
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Glucose Biosensors
  • 4.2.2 Cholesterol Biosensors
  • 4.2.3 Lactate Biosensors
  • 4.2.4 Blood Gas Biosensors
  • 4.2.5 Others
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Electrochemical Biosensors
  • 4.3.2 Optical Biosensors
  • 4.3.3 Thermal Biosensors
  • 4.3.4 Piezoelectric Biosensors
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Component (2020-2035)
  • 4.4.1 Bioreceptor
  • 4.4.2 Transducer
  • 4.4.3 Electronics
  • 4.4.4 Display
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Cancer Detection
  • 4.5.2 Cardiovascular Diseases
  • 4.5.3 Infectious Diseases
  • 4.5.4 Diabetes Management
  • 4.5.5 Neurological Disorders
  • 4.5.6 Others
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Hospitals
  • 4.6.2 Diagnostic Laboratories
  • 4.6.3 Research Institutes
  • 4.6.4 Home Healthcare
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Material Type (2020-2035)
  • 4.7.1 Nanomaterials
  • 4.7.2 Polymers
  • 4.7.3 Biological Materials
  • 4.7.4 Others
• 4.8 Market Size & Forecast by Device (2020-2035)
  • 4.8.1 Point-of-Care Devices
  • 4.8.2 Home Diagnostics
  • 4.8.3 Clinical Devices
  • 4.8.4 Others
• 4.9 Market Size & Forecast by Functionality (2020-2035)
  • 4.9.1 Single-Use Biosensors
  • 4.9.2 Continuous Monitoring Biosensors
  • 4.9.3 Others
• 4.10 Market Size & Forecast by Solutions (2020-2035)
  • 4.10.1 Integrated Systems
  • 4.10.2 Standalone Devices
  • 4.10.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Component
    • 5.2.1.5 Application
    • 5.2.1.6 End User
    • 5.2.1.7 Material Type
    • 5.2.1.8 Device
    • 5.2.1.9 Functionality
    • 5.2.1.10 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Component
    • 5.2.2.5 Application
    • 5.2.2.6 End User
    • 5.2.2.7 Material Type
    • 5.2.2.8 Device
    • 5.2.2.9 Functionality
    • 5.2.2.10 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Component
    • 5.2.3.5 Application
    • 5.2.3.6 End User
    • 5.2.3.7 Material Type
    • 5.2.3.8 Device
    • 5.2.3.9 Functionality
    • 5.2.3.10 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Component
    • 5.3.1.5 Application
    • 5.3.1.6 End User
    • 5.3.1.7 Material Type
    • 5.3.1.8 Device
    • 5.3.1.9 Functionality
    • 5.3.1.10 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Component
    • 5.3.2.5 Application
    • 5.3.2.6 End User
    • 5.3.2.7 Material Type
    • 5.3.2.8 Device
    • 5.3.2.9 Functionality
    • 5.3.2.10 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Component
    • 5.3.3.5 Application
    • 5.3.3.6 End User
    • 5.3.3.7 Material Type
    • 5.3.3.8 Device
    • 5.3.3.9 Functionality
    • 5.3.3.10 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Component
    • 5.4.1.5 Application
    • 5.4.1.6 End User
    • 5.4.1.7 Material Type
    • 5.4.1.8 Device
    • 5.4.1.9 Functionality
    • 5.4.1.10 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Component
    • 5.4.2.5 Application
    • 5.4.2.6 End User
    • 5.4.2.7 Material Type
    • 5.4.2.8 Device
    • 5.4.2.9 Functionality
    • 5.4.2.10 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Component
    • 5.4.3.5 Application
    • 5.4.3.6 End User
    • 5.4.3.7 Material Type
    • 5.4.3.8 Device
    • 5.4.3.9 Functionality
    • 5.4.3.10 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Component
    • 5.4.4.5 Application
    • 5.4.4.6 End User
    • 5.4.4.7 Material Type
    • 5.4.4.8 Device
    • 5.4.4.9 Functionality
    • 5.4.4.10 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Component
    • 5.4.5.5 Application
    • 5.4.5.6 End User
    • 5.4.5.7 Material Type
    • 5.4.5.8 Device
    • 5.4.5.9 Functionality
    • 5.4.5.10 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Component
    • 5.4.6.5 Application
    • 5.4.6.6 End User
    • 5.4.6.7 Material Type
    • 5.4.6.8 Device
    • 5.4.6.9 Functionality
    • 5.4.6.10 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Component
    • 5.4.7.5 Application
    • 5.4.7.6 End User
    • 5.4.7.7 Material Type
    • 5.4.7.8 Device
    • 5.4.7.9 Functionality
    • 5.4.7.10 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Component
    • 5.5.1.5 Application
    • 5.5.1.6 End User
    • 5.5.1.7 Material Type
    • 5.5.1.8 Device
    • 5.5.1.9 Functionality
    • 5.5.1.10 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Component
    • 5.5.2.5 Application
    • 5.5.2.6 End User
    • 5.5.2.7 Material Type
    • 5.5.2.8 Device
    • 5.5.2.9 Functionality
    • 5.5.2.10 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Component
    • 5.5.3.5 Application
    • 5.5.3.6 End User
    • 5.5.3.7 Material Type
    • 5.5.3.8 Device
    • 5.5.3.9 Functionality
    • 5.5.3.10 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Component
    • 5.5.4.5 Application
    • 5.5.4.6 End User
    • 5.5.4.7 Material Type
    • 5.5.4.8 Device
    • 5.5.4.9 Functionality
    • 5.5.4.10 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Component
    • 5.5.5.5 Application
    • 5.5.5.6 End User
    • 5.5.5.7 Material Type
    • 5.5.5.8 Device
    • 5.5.5.9 Functionality
    • 5.5.5.10 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Component
    • 5.5.6.5 Application
    • 5.5.6.6 End User
    • 5.5.6.7 Material Type
    • 5.5.6.8 Device
    • 5.5.6.9 Functionality
    • 5.5.6.10 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Component
    • 5.6.1.5 Application
    • 5.6.1.6 End User
    • 5.6.1.7 Material Type
    • 5.6.1.8 Device
    • 5.6.1.9 Functionality
    • 5.6.1.10 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Component
    • 5.6.2.5 Application
    • 5.6.2.6 End User
    • 5.6.2.7 Material Type
    • 5.6.2.8 Device
    • 5.6.2.9 Functionality
    • 5.6.2.10 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Component
    • 5.6.3.5 Application
    • 5.6.3.6 End User
    • 5.6.3.7 Material Type
    • 5.6.3.8 Device
    • 5.6.3.9 Functionality
    • 5.6.3.10 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Component
    • 5.6.4.5 Application
    • 5.6.4.6 End User
    • 5.6.4.7 Material Type
    • 5.6.4.8 Device
    • 5.6.4.9 Functionality
    • 5.6.4.10 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Component
    • 5.6.5.5 Application
    • 5.6.5.6 End User
    • 5.6.5.7 Material Type
    • 5.6.5.8 Device
    • 5.6.5.9 Functionality
    • 5.6.5.10 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Abbott Laboratories
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Roche Diagnostics
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Medtronic
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Siemens Healthineers
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 GE Healthcare
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Bio-Rad Laboratories
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Thermo Fisher Scientific
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Johnson & Johnson
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Danaher Corporation
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Becton Dickinson
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 PerkinElmer
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Agilent Technologies
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Horiba
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Nova Biomedical
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Sysmex Corporation
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Biomerieux
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Qiagen
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Illumina
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Hologic
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Alere
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us